Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
2024-12-12
|
1 week ago |
EP PerMed - New Fast Track and Venture Creator Programmes |
2024-12-10
|
1 week ago |
ERDERA - 2025 Call on pre-clinical therapy studies for rare diseases open |
2024-11-26
|
3 weeks ago |
Strategic Research and Innovation Agenda on pandemic preparedness - Open for consulta... |
2024-10-25
|
1 month ago |
Innovative Health Initiative: draft texts of IHI calls 9 and 10 published |
2024-10-22
|
1 month ago |
Preannouncement - 2025 Joint Transnational Call for Proposals on Rare Disease Therapi... |
2024-10-07
|
2 months ago |
EIT Health Flagships 2025 - Call on Digital Transformation of Healthcare |
2024-10-01
|
2 months ago |
Innovative Health Initiative - A novel, applicant-driven approach for the next call f... |
2024-09-25
|
2 months ago |
Submitted proposals - Cancer Mission 2024 Call |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Horizon Europe Digital Europe Defence
The NCP Flanders team wishes you happy holidays and all the best for 2025! Please note that our offices are closed between Christmas and new year. read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.